SCHEMBL4981663

SCHEMBL4981663

NC(=O)N(CCc1cccc(OC(F)(F)F)c1)CCc1cccc(OC(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.49
CHRM2 P08172 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
CNR1 P21554 1/20 0.48
DAO P14920 1/20 0.48
EPHX1 P07099 1/20 0.47
CETP P11597 2/20 0.47
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
MAPK14 Q16539 1/20 0.45
KDM5A P29375 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
AMPD2 Q01433 1/20 0.44
ACHE P22303 1/20 0.44
FFAR1 O14842 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL934552 0.83 CHRM2 (0.51) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL5724443 0.81 CHRM2 (0.52) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL30487710 0.81 CHRM2 (0.52) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL934428 0.81 PPARG (0.52) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL18605800 0.79 PPARA (0.46) TRPM8CHRM2CHRM1CHRM3DAO
SCHEMBL18605512 0.78 CHRM2 (0.47) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL27997591 0.78 CHRM2 (0.55) CHRM2CHRM1CHRM3CNR1DAO
SCHEMBL6685564 0.78 EPHX1 (0.52) TRPM8CHRM2CHRM1CHRM3CNR1
SCHEMBL15818310 0.77 FFAR1 (0.57) CHRM2CHRM1CHRM3CNR1DAO
SCHEMBL1271844 0.77 FFAR1 (0.67) CHRM2CHRM1CHRM3CNR1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed